These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14510657)

  • 1. Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators.
    Saeed M; Jin A; Pontone G; Higgins S; Gold M; Harari D; Nunley S; Link MS; Homoud MK; Estes NA; Wang PJ;
    Ann Noninvasive Electrocardiol; 2003 Jul; 8(3):219-26. PubMed ID: 14510657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems.
    Weretka S; Michaelsen J; Becker R; Karle CA; Voss F; Hilbel T; Osswald BR; Bahner ML; Senges JC; Kuebler W; Schoels W
    Pacing Clin Electrophysiol; 2003 Jan; 26(1 Pt 1):65-70. PubMed ID: 12685142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.
    Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH
    Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with a dual chamber implantable defibrillator.
    Kühlkamp V; Wilkoff BL; Brown AB; Volosin KJ; Hügl BJ; Stafford W; Cameron DA
    Pacing Clin Electrophysiol; 2002 Jul; 25(7):1041-8. PubMed ID: 12164444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1309-19. PubMed ID: 11196552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
    Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
    Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensing and detection in Medtronic implantable cardioverter defibrillators.
    Brown ML; Swerdlow CD
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):193-212. PubMed ID: 27624809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination between ventricular and supraventricular tachycardia by dual chamber cardioverter defibrillators: importance of the atrial sensing function.
    Israel CW; Grönefeld G; Iscolo N; Stöppler C; Hohnloser SH
    Pacing Clin Electrophysiol; 2001 Feb; 24(2):183-90. PubMed ID: 11270697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.
    Berenbom LD; Weiford BC; Vacek JL; Emert MP; Hall WJ; Andrews ML; McNitt S; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):429-35. PubMed ID: 16255753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transvenous defibrillation leads: high incidence of failure during long-term follow-up.
    Dorwarth U; Frey B; Dugas M; Matis T; Fiek M; Schmoeckel M; Remp T; Durchlaub I; Gerth A; Steinbeck G; Hoffmann E
    J Cardiovasc Electrophysiol; 2003 Jan; 14(1):38-43. PubMed ID: 12625608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention.
    Friedman PA; Bradley D; Koestler C; Slusser J; Hodge D; Bailey K; Kusumoto F; Munger TM; Militanu A; Glikson M
    Europace; 2014 Oct; 16(10):1460-8. PubMed ID: 24928948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home monitoring of implantable cardioverter-defibrillators: interpretation reliability of the second-generation "IEGM Online" system.
    Nägele H; Lipoldová J; Oswald H; Klein G; Elvan A; Vester E; Bauer W; Bondke H; Reif S; Daub C; Menzel F; Schrader J; Zach G
    Europace; 2015 Apr; 17(4):584-90. PubMed ID: 25567067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is ventricular sensing always right, when it is left?
    Biffi M; de Zan G; Massaro G; Angeletti A; Martignani C; Boriani G; Diemberger I; Ziacchi M
    Clin Cardiol; 2018 Sep; 41(9):1238-1245. PubMed ID: 30054904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Stability and Clinical Utility of Amplified Atrial Electrograms in a Single-Lead ICD System with Floating Atrial Electrodes.
    Worden NE; Alqasrawi M; Mazur A
    Pacing Clin Electrophysiol; 2016 Dec; 39(12):1327-1334. PubMed ID: 27778352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Undersensing by a Noise Detection Algorithm That Utilizes Far-Field Electrograms With Near-Field Bandpass Filtering.
    Koneru JN; Swerdlow CD; Ploux S; Sharma PS; Kaszala K; Tan AY; Huizar JF; Vijayaraman P; Kenigsberg D; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):224-232. PubMed ID: 27957764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.